Live Attenuated Japanese Encephalitis Vaccine - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Live Attenuated Japanese Encephalitis Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Live Attenuated Japanese Encephalitis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Live Attenuated Japanese Encephalitis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Epidemic Japanese encephalitis (hereinafter referred to as "JE") is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report studies and analyses global Live Attenuated Japanese Encephalitis Vaccine status and future trends, helps the client to determine the Live Attenuated Japanese Encephalitis Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Live Attenuated Japanese Encephalitis Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Live Attenuated Japanese Encephalitis Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Live Attenuated Japanese Encephalitis Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Live Attenuated Japanese Encephalitis Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Live Attenuated Japanese Encephalitis Vaccine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Live Attenuated Japanese Encephalitis Vaccine key producing regions, capacity, production, and year over year growth
(6) Live Attenuated Japanese Encephalitis Vaccine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Temple of Heaven Biological Products
Valneva
Bharat Biotech
Cheng Da Biology
Biocelect Pty Ltd
Glovax Co., Ltd.
Market segment by Type, covers
0.5ml
1ml
2.5ml
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Live Attenuated Japanese Encephalitis Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Live Attenuated Japanese Encephalitis Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Live Attenuated Japanese Encephalitis Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Live Attenuated Japanese Encephalitis Vaccine, percent & CAGR, 2018-2029
Chapter 5: Live Attenuated Japanese Encephalitis Vaccine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Live Attenuated Japanese Encephalitis Vaccine Definition
1.2 Global Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Live Attenuated Japanese Encephalitis Vaccine Market Size，2018-2029
1.2.2 By Sales Quantity, Global Live Attenuated Japanese Encephalitis Vaccine Market Size，2018-2029
1.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP)，2018-2029
1.3 China Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Live Attenuated Japanese Encephalitis Vaccine Market Size，2018-2029
1.3.2 By Sales Quantity, China Live Attenuated Japanese Encephalitis Vaccine Market Size，2018-2029
1.3.3 China Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP)， 2018-2029
1.4 Share of China Live Attenuated Japanese Encephalitis Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Live Attenuated Japanese Encephalitis Vaccine Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Live Attenuated Japanese Encephalitis Vaccine Market Share in Global, 2018-2029
1.4.3 Live Attenuated Japanese Encephalitis Vaccine Market Size: China VS Global, 2018-2029
1.5 Live Attenuated Japanese Encephalitis Vaccine Market Dynamics
1.5.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
1.5.2 Live Attenuated Japanese Encephalitis Vaccine Market Restraints
1.5.3 Live Attenuated Japanese Encephalitis Vaccine Industry Trends
1.5.4 Live Attenuated Japanese Encephalitis Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Live Attenuated Japanese Encephalitis Vaccine, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Live Attenuated Japanese Encephalitis Vaccine, Global Market Share by Company, 2018-2023
2.3 Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Live Attenuated Japanese Encephalitis Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Live Attenuated Japanese Encephalitis Vaccine Concentration Ratio
2.6 Global Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Product Type
2.8 Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
2.9 Live Attenuated Japanese Encephalitis Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Live Attenuated Japanese Encephalitis Vaccine, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Live Attenuated Japanese Encephalitis Vaccine, China Market Share by Company, 2018-2023
3.3 China Live Attenuated Japanese Encephalitis Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Live Attenuated Japanese Encephalitis Vaccine Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Live Attenuated Japanese Encephalitis Vaccine Capacity by Region
4.3 Global Live Attenuated Japanese Encephalitis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Live Attenuated Japanese Encephalitis Vaccine Production by Region, 2018-2029
4.5 Global Live Attenuated Japanese Encephalitis Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Live Attenuated Japanese Encephalitis Vaccine Industry Chain
5.2 Live Attenuated Japanese Encephalitis Vaccine Upstream Analysis
5.2.1 Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Live Attenuated Japanese Encephalitis Vaccine Production Mode
5.6 Live Attenuated Japanese Encephalitis Vaccine Procurement Model
5.7 Live Attenuated Japanese Encephalitis Vaccine Industry Sales Model and Sales Channels
5.7.1 Live Attenuated Japanese Encephalitis Vaccine Sales Model
5.7.2 Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
6 Sights by Type
6.1 Live Attenuated Japanese Encephalitis Vaccine Classification
6.1.1 0.5ml
6.1.2 1ml
6.1.3 2.5ml
6.2 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029
6.4 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029
6.5 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Live Attenuated Japanese Encephalitis Vaccine Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029
7.4 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029
7.5 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029
8.3 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Live Attenuated Japanese Encephalitis Vaccine & Forecasts, 2018-2029
8.4.2 By Country, North America Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029
9.3 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.4.2 By Type, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.5.2 By Type, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.6.2 By Type, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.7.2 By Type, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.8.2 By Type, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.10.2 By Type, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis
10.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis Company Profile and Main Business
10.1.5 Novartis Recent Developments
10.2 Sanofi
10.2.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.2.2 Sanofi Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sanofi Company Profile and Main Business
10.2.5 Sanofi Recent Developments
10.3 Chengdu Institute of Biological Products
10.3.1 Chengdu Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
10.3.2 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Chengdu Institute of Biological Products Company Profile and Main Business
10.3.5 Chengdu Institute of Biological Products Recent Developments
10.4 Wuhan Institute of Biological Products
10.4.1 Wuhan Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
10.4.2 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Wuhan Institute of Biological Products Company Profile and Main Business
10.4.5 Wuhan Institute of Biological Products Recent Developments
10.5 Lanzhou Institute of Biological Products
10.5.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
10.5.2 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Lanzhou Institute of Biological Products Company Profile and Main Business
10.5.5 Lanzhou Institute of Biological Products Recent Developments
10.6 Beijing Temple of Heaven Biological Products
10.6.1 Beijing Temple of Heaven Biological Products Company Information, Head Office, Market Area, and Industry Position
10.6.2 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Beijing Temple of Heaven Biological Products Company Profile and Main Business
10.6.5 Beijing Temple of Heaven Biological Products Recent Developments
10.7 Valneva
10.7.1 Valneva Company Information, Head Office, Market Area, and Industry Position
10.7.2 Valneva Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Valneva Company Profile and Main Business
10.7.5 Valneva Recent Developments
10.8 Bharat Biotech
10.8.1 Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bharat Biotech Company Profile and Main Business
10.8.5 Bharat Biotech Recent Developments
10.9 Cheng Da Biology
10.9.1 Cheng Da Biology Company Information, Head Office, Market Area, and Industry Position
10.9.2 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Cheng Da Biology Company Profile and Main Business
10.9.5 Cheng Da Biology Recent Developments
10.10 Biocelect Pty Ltd
10.10.1 Biocelect Pty Ltd Company Information, Head Office, Market Area, and Industry Position
10.10.2 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Biocelect Pty Ltd Company Profile and Main Business
10.10.5 Biocelect Pty Ltd Recent Developments
10.11 Glovax Co., Ltd.
10.11.1 Glovax Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.11.2 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
10.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Glovax Co., Ltd. Company Profile and Main Business
10.11.5 Glovax Co., Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Live Attenuated Japanese Encephalitis Vaccine Market Restraints
Table 3. Live Attenuated Japanese Encephalitis Vaccine Market Trends
Table 4. Live Attenuated Japanese Encephalitis Vaccine Industry Policy
Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Product Type
Table 13. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
Table 14. Live Attenuated Japanese Encephalitis Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine Upstream (Raw Materials)
Table 22. Global Live Attenuated Japanese Encephalitis Vaccine Typical Customers
Table 23. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
Table 24. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029
Table 34. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 35. Novartis Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 36. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Novartis Company Profile and Main Business
Table 38. Novartis Recent Developments
Table 39. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 40. Sanofi Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 41. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sanofi Company Profile and Main Business
Table 43. Sanofi Recent Developments
Table 44. Chengdu Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
Table 45. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 46. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Chengdu Institute of Biological Products Company Profile and Main Business
Table 48. Chengdu Institute of Biological Products Recent Developments
Table 49. Wuhan Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
Table 50. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 51. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Wuhan Institute of Biological Products Company Profile and Main Business
Table 53. Wuhan Institute of Biological Products Recent Developments
Table 54. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
Table 55. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 56. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Lanzhou Institute of Biological Products Company Profile and Main Business
Table 58. Lanzhou Institute of Biological Products Recent Developments
Table 59. Beijing Temple of Heaven Biological Products Company Information, Head Office, Market Area, and Industry Position
Table 60. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 61. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Beijing Temple of Heaven Biological Products Company Profile and Main Business
Table 63. Beijing Temple of Heaven Biological Products Recent Developments
Table 64. Valneva Company Information, Head Office, Market Area, and Industry Position
Table 65. Valneva Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 66. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Valneva Company Profile and Main Business
Table 68. Valneva Recent Developments
Table 69. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
Table 70. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 71. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bharat Biotech Company Profile and Main Business
Table 73. Bharat Biotech Recent Developments
Table 74. Cheng Da Biology Company Information, Head Office, Market Area, and Industry Position
Table 75. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 76. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Cheng Da Biology Company Profile and Main Business
Table 78. Cheng Da Biology Recent Developments
Table 79. Biocelect Pty Ltd Company Information, Head Office, Market Area, and Industry Position
Table 80. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 81. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Biocelect Pty Ltd Company Profile and Main Business
Table 83. Biocelect Pty Ltd Recent Developments
Table 84. Glovax Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 85. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application
Table 86. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Glovax Co., Ltd. Company Profile and Main Business
Table 88. Glovax Co., Ltd. Recent Developments
List of Figures
Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture
Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Live Attenuated Japanese Encephalitis Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Live Attenuated Japanese Encephalitis Vaccine Market Share of Global, 2018-2029
Figure 10. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Live Attenuated Japanese Encephalitis Vaccine Key Participants, Market Share, 2022
Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Live Attenuated Japanese Encephalitis Vaccine Industry Chain
Figure 16. Live Attenuated Japanese Encephalitis Vaccine Procurement Model
Figure 17. Live Attenuated Japanese Encephalitis Vaccine Sales Model
Figure 18. Live Attenuated Japanese Encephalitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. 0.5ml
Figure 20. 1ml
Figure 21. 2.5ml
Figure 22. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hospital
Figure 28. Clinic
Figure 29. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029
Figure 36. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022
Figure 38. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022
Figure 40. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022
Figure 42. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|